Table 2.
Renal function and metabolic outcomes in the decreased/stable uric acid and increased uric acid groups.
| Variable | Uric Acid | p | |
|---|---|---|---|
| Decreased/Stable | Increased | ||
| (n = 675) | (n = 230) | ||
| Preop eGFR < 60 | 76 (11.3) | 45 (19.6) | 0.0014 |
| Postop eGFR < 60 | 203 (30.1) | 136 (59.1) | <0.0001 |
| De Novo eGFR < 60 | 124 (18.4) | 89 (38.7) | <0.0001 |
| Preop Proteinuria | 72 (10.7) | 33 (14.4) | 0.1322 |
| Postop Proteinuria | 140 (20.7) | 71 (30.9) | 0.0017 |
| Preop Met Acidosis | 22 (3.6) | 12 (5.2) | 0.1774 |
| Postop Met Acidosis | 79 (11.7) | 48 (20.9) | 0.0005 |
| Preop Osteoporosis | 55 (8.2) | 27 (11.7) | 0.2611 |
| Postop Osteoporosis | 110 (16.3) | 66 (28.7) | <0.0001 |
| Preop Anemia | 106 (15.7) | 55 (23.9) | 0.0049 |
| Postop Anemia | 171 (25.3) | 108 (47.0) | <0.0001 |